- 全部删除
您的购物车当前为空
NF-κB-IN-16 (compound 9) 是 NF-κB 抑制剂与 Cisplatin 的复合物 (Pt(IV) 复合物),表现出高效且低毒的抗肿瘤活性。该化合物会导致 DNA 损伤,诱发线粒体功能失调和活性氧生成,并通过线粒体途径及内质网应激诱导细胞凋亡 (apoptosis)。NF-κB-IN-16 有效抑制 NF-κB/MAPK 信号传导并干扰 PI3K/AKT 信号通路。此外,它在 A549 或 A549/CDDP 异种移植模型中显示出优异的体内抗肿瘤效率及低毒性。
NF-κB-IN-16 (compound 9) 是 NF-κB 抑制剂与 Cisplatin 的复合物 (Pt(IV) 复合物),表现出高效且低毒的抗肿瘤活性。该化合物会导致 DNA 损伤,诱发线粒体功能失调和活性氧生成,并通过线粒体途径及内质网应激诱导细胞凋亡 (apoptosis)。NF-κB-IN-16 有效抑制 NF-κB/MAPK 信号传导并干扰 PI3K/AKT 信号通路。此外,它在 A549 或 A549/CDDP 异种移植模型中显示出优异的体内抗肿瘤效率及低毒性。

NF-κB-IN-16 相关产品
| 产品描述 | NF-κB-IN-16 (compound 9) is a complex of an NF-κB inhibitor and Cisplatin (Pt(IV) complex) with potent and low-toxicity antitumor activity. It can cause DNA damage, induce mitochondrial dysfunction, generate reactive oxygen species, and trigger apoptosis via mitochondrial pathways and endoplasmic reticulum stress. NF-κB-IN-16 effectively inhibits the NF-κB/MAPK signaling pathway and disrupts PI3K/AKT signal transduction. Additionally, it demonstrates excellent in vivo antitumor efficacy and low toxicity in A549 or A549/CDDP xenograft models. |
| 体外活性 | NF-κB-IN-16 (compound 9)(5 μM;24 h)可诱导 A549 细胞凋亡,并将其细胞周期阻滞在 S 期。此外,NF-κB-IN-16 对人类癌细胞展现出细胞毒性,其 IC 50 分别为 0.45 μM (HepG-2)、0.46 μM (HCT-116)、0.73 μM (MCF-7)、以及 0.29 μM (A549)。NF-κB-IN-16 (5 μM; 24 h) 还能诱导 A549 细胞的 DNA 损伤。 |
| 体内活性 | NF-κB-IN-16 (compound 9) 在 A549 异种移植裸鼠模型中,通过腹腔注射(5, 13.9 mg/kg; ip; 21 天)展现出显著的抗肿瘤活性,两种剂量的抑制率分别为 36.2% 和 63.7%。此外,NF-κB-IN-16 同样对 A549/CDPP 异种移植裸鼠模型产生显著的抑制效果。 |
| 分子式 | C26H35Cl3N2O10Pt |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容